Synthetic Peptide Vaccine and Forecast Market
1 Introduction to Research & Analysis Reports
1.1 Synthetic Peptide Vaccine Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Synthetic Peptide Vaccine Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Synthetic Peptide Vaccine Overall Market Size
2.1 Global Synthetic Peptide Vaccine Market Size: 2022 VS 2030
2.2 Global Synthetic Peptide Vaccine Revenue, Prospects & Forecasts: 2018-2030
2.3 Global Synthetic Peptide Vaccine Sales: 2018-2030
3 Company Landscape
3.1 Top Synthetic Peptide Vaccine Players in Global Market
3.2 Top Global Synthetic Peptide Vaccine Companies Ranked by Revenue
3.3 Global Synthetic Peptide Vaccine Revenue by Companies
3.4 Global Synthetic Peptide Vaccine Sales by Companies
3.5 Global Synthetic Peptide Vaccine Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Synthetic Peptide Vaccine Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Synthetic Peptide Vaccine Product Type
3.8 Tier 1, Tier 2 and Tier 3 Synthetic Peptide Vaccine Players in Global Market
3.8.1 List of Global Tier 1 Synthetic Peptide Vaccine Companies
3.8.2 List of Global Tier 2 and Tier 3 Synthetic Peptide Vaccine Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Synthetic Peptide Vaccine Market Size Markets, 2022 & 2030
4.1.2 Solution Phase Synthesis (SPS)
4.1.3 Solid Phase Peptide Synthesis (SPPS)
4.2 By Type - Global Synthetic Peptide Vaccine Revenue & Forecasts
4.2.1 By Type - Global Synthetic Peptide Vaccine Revenue, 2018-2023
4.2.2 By Type - Global Synthetic Peptide Vaccine Revenue, 2024-2030
4.2.3 By Type - Global Synthetic Peptide Vaccine Revenue Market Share, 2018-2030
4.3 By Type - Global Synthetic Peptide Vaccine Sales & Forecasts
4.3.1 By Type - Global Synthetic Peptide Vaccine Sales, 2018-2023
4.3.2 By Type - Global Synthetic Peptide Vaccine Sales, 2024-2030
4.3.3 By Type - Global Synthetic Peptide Vaccine Sales Market Share, 2018-2030
4.4 By Type - Global Synthetic Peptide Vaccine Price (Manufacturers Selling Prices), 2018-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Synthetic Peptide Vaccine Market Size, 2022 & 2030
5.1.2 Prostate Cancer
5.1.3 Breast Cancer
5.1.4 Gastric Cancer
5.1.5 Lung Cancer
5.1.6 Pancreatic Cancer
5.1.7 Others
5.2 By Application - Global Synthetic Peptide Vaccine Revenue & Forecasts
5.2.1 By Application - Global Synthetic Peptide Vaccine Revenue, 2018-2023
5.2.2 By Application - Global Synthetic Peptide Vaccine Revenue, 2024-2030
5.2.3 By Application - Global Synthetic Peptide Vaccine Revenue Market Share, 2018-2030
5.3 By Application - Global Synthetic Peptide Vaccine Sales & Forecasts
5.3.1 By Application - Global Synthetic Peptide Vaccine Sales, 2018-2023
5.3.2 By Application - Global Synthetic Peptide Vaccine Sales, 2024-2030
5.3.3 By Application - Global Synthetic Peptide Vaccine Sales Market Share, 2018-2030
5.4 By Application - Global Synthetic Peptide Vaccine Price (Manufacturers Selling Prices), 2018-2030
6 Sights by Region
6.1 By Region - Global Synthetic Peptide Vaccine Market Size, 2022 & 2030
6.2 By Region - Global Synthetic Peptide Vaccine Revenue & Forecasts
6.2.1 By Region - Global Synthetic Peptide Vaccine Revenue, 2018-2023
6.2.2 By Region - Global Synthetic Peptide Vaccine Revenue, 2024-2030
6.2.3 By Region - Global Synthetic Peptide Vaccine Revenue Market Share, 2018-2030
6.3 By Region - Global Synthetic Peptide Vaccine Sales & Forecasts
6.3.1 By Region - Global Synthetic Peptide Vaccine Sales, 2018-2023
6.3.2 By Region - Global Synthetic Peptide Vaccine Sales, 2024-2030
6.3.3 By Region - Global Synthetic Peptide Vaccine Sales Market Share, 2018-2030
6.4 North America
6.4.1 By Country - North America Synthetic Peptide Vaccine Revenue, 2018-2030
6.4.2 By Country - North America Synthetic Peptide Vaccine Sales, 2018-2030
6.4.3 US Synthetic Peptide Vaccine Market Size, 2018-2030
6.4.4 Canada Synthetic Peptide Vaccine Market Size, 2018-2030
6.4.5 Mexico Synthetic Peptide Vaccine Market Size, 2018-2030
6.5 Europe
6.5.1 By Country - Europe Synthetic Peptide Vaccine Revenue, 2018-2030
6.5.2 By Country - Europe Synthetic Peptide Vaccine Sales, 2018-2030
6.5.3 Germany Synthetic Peptide Vaccine Market Size, 2018-2030
6.5.4 France Synthetic Peptide Vaccine Market Size, 2018-2030
6.5.5 U.K. Synthetic Peptide Vaccine Market Size, 2018-2030
6.5.6 Italy Synthetic Peptide Vaccine Market Size, 2018-2030
6.5.7 Russia Synthetic Peptide Vaccine Market Size, 2018-2030
6.5.8 Nordic Countries Synthetic Peptide Vaccine Market Size, 2018-2030
6.5.9 Benelux Synthetic Peptide Vaccine Market Size, 2018-2030
6.6 Asia
6.6.1 By Region - Asia Synthetic Peptide Vaccine Revenue, 2018-2030
6.6.2 By Region - Asia Synthetic Peptide Vaccine Sales, 2018-2030
6.6.3 China Synthetic Peptide Vaccine Market Size, 2018-2030
6.6.4 Japan Synthetic Peptide Vaccine Market Size, 2018-2030
6.6.5 South Korea Synthetic Peptide Vaccine Market Size, 2018-2030
6.6.6 Southeast Asia Synthetic Peptide Vaccine Market Size, 2018-2030
6.6.7 India Synthetic Peptide Vaccine Market Size, 2018-2030
6.7 South America
6.7.1 By Country - South America Synthetic Peptide Vaccine Revenue, 2018-2030
6.7.2 By Country - South America Synthetic Peptide Vaccine Sales, 2018-2030
6.7.3 Brazil Synthetic Peptide Vaccine Market Size, 2018-2030
6.7.4 Argentina Synthetic Peptide Vaccine Market Size, 2018-2030
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Synthetic Peptide Vaccine Revenue, 2018-2030
6.8.2 By Country - Middle East & Africa Synthetic Peptide Vaccine Sales, 2018-2030
6.8.3 Turkey Synthetic Peptide Vaccine Market Size, 2018-2030
6.8.4 Israel Synthetic Peptide Vaccine Market Size, 2018-2030
6.8.5 Saudi Arabia Synthetic Peptide Vaccine Market Size, 2018-2030
6.8.6 UAE Synthetic Peptide Vaccine Market Size, 2018-2030
7 Manufacturers & Brands Profiles
7.1 Anergis
7.1.1 Anergis Company Summary
7.1.2 Anergis Business Overview
7.1.3 Anergis Synthetic Peptide Vaccine Major Product Offerings
7.1.4 Anergis Synthetic Peptide Vaccine Sales and Revenue in Global (2018-2023)
7.1.5 Anergis Key News & Latest Developments
7.2 Antigen Express
7.2.1 Antigen Express Company Summary
7.2.2 Antigen Express Business Overview
7.2.3 Antigen Express Synthetic Peptide Vaccine Major Product Offerings
7.2.4 Antigen Express Synthetic Peptide Vaccine Sales and Revenue in Global (2018-2023)
7.2.5 Antigen Express Key News & Latest Developments
7.3 Apitope Technology
7.3.1 Apitope Technology Company Summary
7.3.2 Apitope Technology Business Overview
7.3.3 Apitope Technology Synthetic Peptide Vaccine Major Product Offerings
7.3.4 Apitope Technology Synthetic Peptide Vaccine Sales and Revenue in Global (2018-2023)
7.3.5 Apitope Technology Key News & Latest Developments
7.4 Artificial Cell Technologies
7.4.1 Artificial Cell Technologies Company Summary
7.4.2 Artificial Cell Technologies Business Overview
7.4.3 Artificial Cell Technologies Synthetic Peptide Vaccine Major Product Offerings
7.4.4 Artificial Cell Technologies Synthetic Peptide Vaccine Sales and Revenue in Global (2018-2023)
7.4.5 Artificial Cell Technologies Key News & Latest Developments
7.5 Benovus Bio
7.5.1 Benovus Bio Company Summary
7.5.2 Benovus Bio Business Overview
7.5.3 Benovus Bio Synthetic Peptide Vaccine Major Product Offerings
7.5.4 Benovus Bio Synthetic Peptide Vaccine Sales and Revenue in Global (2018-2023)
7.5.5 Benovus Bio Key News & Latest Developments
7.6 Celgene Corporation
7.6.1 Celgene Corporation Company Summary
7.6.2 Celgene Corporation Business Overview
7.6.3 Celgene Corporation Synthetic Peptide Vaccine Major Product Offerings
7.6.4 Celgene Corporation Synthetic Peptide Vaccine Sales and Revenue in Global (2018-2023)
7.6.5 Celgene Corporation Key News & Latest Developments
7.7 Immatics biotechnologies
7.7.1 Immatics biotechnologies Company Summary
7.7.2 Immatics biotechnologies Business Overview
7.7.3 Immatics biotechnologies Synthetic Peptide Vaccine Major Product Offerings
7.7.4 Immatics biotechnologies Synthetic Peptide Vaccine Sales and Revenue in Global (2018-2023)
7.7.5 Immatics biotechnologies Key News & Latest Developments
7.8 Merck
7.8.1 Merck Company Summary
7.8.2 Merck Business Overview
7.8.3 Merck Synthetic Peptide Vaccine Major Product Offerings
7.8.4 Merck Synthetic Peptide Vaccine Sales and Revenue in Global (2018-2023)
7.8.5 Merck Key News & Latest Developments
7.9 ImmunoCellular Therapeutics
7.9.1 ImmunoCellular Therapeutics Company Summary
7.9.2 ImmunoCellular Therapeutics Business Overview
7.9.3 ImmunoCellular Therapeutics Synthetic Peptide Vaccine Major Product Offerings
7.9.4 ImmunoCellular Therapeutics Synthetic Peptide Vaccine Sales and Revenue in Global (2018-2023)
7.9.5 ImmunoCellular Therapeutics Key News & Latest Developments
7.10 ISA Pharmaceuticals
7.10.1 ISA Pharmaceuticals Company Summary
7.10.2 ISA Pharmaceuticals Business Overview
7.10.3 ISA Pharmaceuticals Synthetic Peptide Vaccine Major Product Offerings
7.10.4 ISA Pharmaceuticals Synthetic Peptide Vaccine Sales and Revenue in Global (2018-2023)
7.10.5 ISA Pharmaceuticals Key News & Latest Developments
7.11 Lytix Biopharma
7.11.1 Lytix Biopharma Company Summary
7.11.2 Lytix Biopharma Synthetic Peptide Vaccine Business Overview
7.11.3 Lytix Biopharma Synthetic Peptide Vaccine Major Product Offerings
7.11.4 Lytix Biopharma Synthetic Peptide Vaccine Sales and Revenue in Global (2018-2023)
7.11.5 Lytix Biopharma Key News & Latest Developments
7.12 Spotlight Innovation
7.12.1 Spotlight Innovation Company Summary
7.12.2 Spotlight Innovation Synthetic Peptide Vaccine Business Overview
7.12.3 Spotlight Innovation Synthetic Peptide Vaccine Major Product Offerings
7.12.4 Spotlight Innovation Synthetic Peptide Vaccine Sales and Revenue in Global (2018-2023)
7.12.5 Spotlight Innovation Key News & Latest Developments
7.13 OncoTherapy Science
7.13.1 OncoTherapy Science Company Summary
7.13.2 OncoTherapy Science Synthetic Peptide Vaccine Business Overview
7.13.3 OncoTherapy Science Synthetic Peptide Vaccine Major Product Offerings
7.13.4 OncoTherapy Science Synthetic Peptide Vaccine Sales and Revenue in Global (2018-2023)
7.13.5 OncoTherapy Science Key News & Latest Developments
7.14 Peptech
7.14.1 Peptech Company Summary
7.14.2 Peptech Business Overview
7.14.3 Peptech Synthetic Peptide Vaccine Major Product Offerings
7.14.4 Peptech Synthetic Peptide Vaccine Sales and Revenue in Global (2018-2023)
7.14.5 Peptech Key News & Latest Developments
7.15 Pharmasyntez
7.15.1 Pharmasyntez Company Summary
7.15.2 Pharmasyntez Business Overview
7.15.3 Pharmasyntez Synthetic Peptide Vaccine Major Product Offerings
7.15.4 Pharmasyntez Synthetic Peptide Vaccine Sales and Revenue in Global (2018-2023)
7.15.5 Pharmasyntez Key News & Latest Developments
7.16 Sumitomo Dainippon Pharma
7.16.1 Sumitomo Dainippon Pharma Company Summary
7.16.2 Sumitomo Dainippon Pharma Business Overview
7.16.3 Sumitomo Dainippon Pharma Synthetic Peptide Vaccine Major Product Offerings
7.16.4 Sumitomo Dainippon Pharma Synthetic Peptide Vaccine Sales and Revenue in Global (2018-2023)
7.16.5 Sumitomo Dainippon Pharma Key News & Latest Developments
7.17 TapImmune
7.17.1 TapImmune Company Summary
7.17.2 TapImmune Business Overview
7.17.3 TapImmune Synthetic Peptide Vaccine Major Product Offerings
7.17.4 TapImmune Synthetic Peptide Vaccine Sales and Revenue in Global (2018-2023)
7.17.5 TapImmune Key News & Latest Developments
7.18 Targovax
7.18.1 Targovax Company Summary
7.18.2 Targovax Business Overview
7.18.3 Targovax Synthetic Peptide Vaccine Major Product Offerings
7.18.4 Targovax Synthetic Peptide Vaccine Sales and Revenue in Global (2018-2023)
7.18.5 Targovax Key News & Latest Developments
8 Global Synthetic Peptide Vaccine Production Capacity, Analysis
8.1 Global Synthetic Peptide Vaccine Production Capacity, 2018-2030
8.2 Synthetic Peptide Vaccine Production Capacity of Key Manufacturers in Global Market
8.3 Global Synthetic Peptide Vaccine Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Synthetic Peptide Vaccine Supply Chain Analysis
10.1 Synthetic Peptide Vaccine Industry Value Chain
10.2 Synthetic Peptide Vaccine Upstream Market
10.3 Synthetic Peptide Vaccine Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Synthetic Peptide Vaccine Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
List of Tables
Table 1. Key Players of Synthetic Peptide Vaccine in Global Market
Table 2. Top Synthetic Peptide Vaccine Players in Global Market, Ranking by Revenue (2022)
Table 3. Global Synthetic Peptide Vaccine Revenue by Companies, (US$, Mn), 2018-2023
Table 4. Global Synthetic Peptide Vaccine Revenue Share by Companies, 2018-2023
Table 5. Global Synthetic Peptide Vaccine Sales by Companies, (K Dose), 2018-2023
Table 6. Global Synthetic Peptide Vaccine Sales Share by Companies, 2018-2023
Table 7. Key Manufacturers Synthetic Peptide Vaccine Price (2018-2023) & (US$/Dose)
Table 8. Global Manufacturers Synthetic Peptide Vaccine Product Type
Table 9. List of Global Tier 1 Synthetic Peptide Vaccine Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Synthetic Peptide Vaccine Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Synthetic Peptide Vaccine Revenue, (US$, Mn), 2022 & 2030
Table 12. By Type - Global Synthetic Peptide Vaccine Revenue (US$, Mn), 2018-2023
Table 13. By Type - Global Synthetic Peptide Vaccine Revenue (US$, Mn), 2024-2030
Table 14. By Type - Global Synthetic Peptide Vaccine Sales (K Dose), 2018-2023
Table 15. By Type - Global Synthetic Peptide Vaccine Sales (K Dose), 2024-2030
Table 16. By Application ? Global Synthetic Peptide Vaccine Revenue, (US$, Mn), 2022 & 2030
Table 17. By Application - Global Synthetic Peptide Vaccine Revenue (US$, Mn), 2018-2023
Table 18. By Application - Global Synthetic Peptide Vaccine Revenue (US$, Mn), 2024-2030
Table 19. By Application - Global Synthetic Peptide Vaccine Sales (K Dose), 2018-2023
Table 20. By Application - Global Synthetic Peptide Vaccine Sales (K Dose), 2024-2030
Table 21. By Region ? Global Synthetic Peptide Vaccine Revenue, (US$, Mn), 2022 VS 2030
Table 22. By Region - Global Synthetic Peptide Vaccine Revenue (US$, Mn), 2018-2023
Table 23. By Region - Global Synthetic Peptide Vaccine Revenue (US$, Mn), 2024-2030
Table 24. By Region - Global Synthetic Peptide Vaccine Sales (K Dose), 2018-2023
Table 25. By Region - Global Synthetic Peptide Vaccine Sales (K Dose), 2024-2030
Table 26. By Country - North America Synthetic Peptide Vaccine Revenue, (US$, Mn), 2018-2023
Table 27. By Country - North America Synthetic Peptide Vaccine Revenue, (US$, Mn), 2024-2030
Table 28. By Country - North America Synthetic Peptide Vaccine Sales, (K Dose), 2018-2023
Table 29. By Country - North America Synthetic Peptide Vaccine Sales, (K Dose), 2024-2030
Table 30. By Country - Europe Synthetic Peptide Vaccine Revenue, (US$, Mn), 2018-2023
Table 31. By Country - Europe Synthetic Peptide Vaccine Revenue, (US$, Mn), 2024-2030
Table 32. By Country - Europe Synthetic Peptide Vaccine Sales, (K Dose), 2018-2023
Table 33. By Country - Europe Synthetic Peptide Vaccine Sales, (K Dose), 2024-2030
Table 34. By Region - Asia Synthetic Peptide Vaccine Revenue, (US$, Mn), 2018-2023
Table 35. By Region - Asia Synthetic Peptide Vaccine Revenue, (US$, Mn), 2024-2030
Table 36. By Region - Asia Synthetic Peptide Vaccine Sales, (K Dose), 2018-2023
Table 37. By Region - Asia Synthetic Peptide Vaccine Sales, (K Dose), 2024-2030
Table 38. By Country - South America Synthetic Peptide Vaccine Revenue, (US$, Mn), 2018-2023
Table 39. By Country - South America Synthetic Peptide Vaccine Revenue, (US$, Mn), 2024-2030
Table 40. By Country - South America Synthetic Peptide Vaccine Sales, (K Dose), 2018-2023
Table 41. By Country - South America Synthetic Peptide Vaccine Sales, (K Dose), 2024-2030
Table 42. By Country - Middle East & Africa Synthetic Peptide Vaccine Revenue, (US$, Mn), 2018-2023
Table 43. By Country - Middle East & Africa Synthetic Peptide Vaccine Revenue, (US$, Mn), 2024-2030
Table 44. By Country - Middle East & Africa Synthetic Peptide Vaccine Sales, (K Dose), 2018-2023
Table 45. By Country - Middle East & Africa Synthetic Peptide Vaccine Sales, (K Dose), 2024-2030
Table 46. Anergis Company Summary
Table 47. Anergis Synthetic Peptide Vaccine Product Offerings
Table 48. Anergis Synthetic Peptide Vaccine Sales (K Dose), Revenue (US$, Mn) and Average Price (US$/Dose) (2018-2023)
Table 49. Anergis Key News & Latest Developments
Table 50. Antigen Express Company Summary
Table 51. Antigen Express Synthetic Peptide Vaccine Product Offerings
Table 52. Antigen Express Synthetic Peptide Vaccine Sales (K Dose), Revenue (US$, Mn) and Average Price (US$/Dose) (2018-2023)
Table 53. Antigen Express Key News & Latest Developments
Table 54. Apitope Technology Company Summary
Table 55. Apitope Technology Synthetic Peptide Vaccine Product Offerings
Table 56. Apitope Technology Synthetic Peptide Vaccine Sales (K Dose), Revenue (US$, Mn) and Average Price (US$/Dose) (2018-2023)
Table 57. Apitope Technology Key News & Latest Developments
Table 58. Artificial Cell Technologies Company Summary
Table 59. Artificial Cell Technologies Synthetic Peptide Vaccine Product Offerings
Table 60. Artificial Cell Technologies Synthetic Peptide Vaccine Sales (K Dose), Revenue (US$, Mn) and Average Price (US$/Dose) (2018-2023)
Table 61. Artificial Cell Technologies Key News & Latest Developments
Table 62. Benovus Bio Company Summary
Table 63. Benovus Bio Synthetic Peptide Vaccine Product Offerings
Table 64. Benovus Bio Synthetic Peptide Vaccine Sales (K Dose), Revenue (US$, Mn) and Average Price (US$/Dose) (2018-2023)
Table 65. Benovus Bio Key News & Latest Developments
Table 66. Celgene Corporation Company Summary
Table 67. Celgene Corporation Synthetic Peptide Vaccine Product Offerings
Table 68. Celgene Corporation Synthetic Peptide Vaccine Sales (K Dose), Revenue (US$, Mn) and Average Price (US$/Dose) (2018-2023)
Table 69. Celgene Corporation Key News & Latest Developments
Table 70. Immatics biotechnologies Company Summary
Table 71. Immatics biotechnologies Synthetic Peptide Vaccine Product Offerings
Table 72. Immatics biotechnologies Synthetic Peptide Vaccine Sales (K Dose), Revenue (US$, Mn) and Average Price (US$/Dose) (2018-2023)
Table 73. Immatics biotechnologies Key News & Latest Developments
Table 74. Merck Company Summary
Table 75. Merck Synthetic Peptide Vaccine Product Offerings
Table 76. Merck Synthetic Peptide Vaccine Sales (K Dose), Revenue (US$, Mn) and Average Price (US$/Dose) (2018-2023)
Table 77. Merck Key News & Latest Developments
Table 78. ImmunoCellular Therapeutics Company Summary
Table 79. ImmunoCellular Therapeutics Synthetic Peptide Vaccine Product Offerings
Table 80. ImmunoCellular Therapeutics Synthetic Peptide Vaccine Sales (K Dose), Revenue (US$, Mn) and Average Price (US$/Dose) (2018-2023)
Table 81. ImmunoCellular Therapeutics Key News & Latest Developments
Table 82. ISA Pharmaceuticals Company Summary
Table 83. ISA Pharmaceuticals Synthetic Peptide Vaccine Product Offerings
Table 84. ISA Pharmaceuticals Synthetic Peptide Vaccine Sales (K Dose), Revenue (US$, Mn) and Average Price (US$/Dose) (2018-2023)
Table 85. ISA Pharmaceuticals Key News & Latest Developments
Table 86. Lytix Biopharma Company Summary
Table 87. Lytix Biopharma Synthetic Peptide Vaccine Product Offerings
Table 88. Lytix Biopharma Synthetic Peptide Vaccine Sales (K Dose), Revenue (US$, Mn) and Average Price (US$/Dose) (2018-2023)
Table 89. Lytix Biopharma Key News & Latest Developments
Table 90. Spotlight Innovation Company Summary
Table 91. Spotlight Innovation Synthetic Peptide Vaccine Product Offerings
Table 92. Spotlight Innovation Synthetic Peptide Vaccine Sales (K Dose), Revenue (US$, Mn) and Average Price (US$/Dose) (2018-2023)
Table 93. Spotlight Innovation Key News & Latest Developments
Table 94. OncoTherapy Science Company Summary
Table 95. OncoTherapy Science Synthetic Peptide Vaccine Product Offerings
Table 96. OncoTherapy Science Synthetic Peptide Vaccine Sales (K Dose), Revenue (US$, Mn) and Average Price (US$/Dose) (2018-2023)
Table 97. OncoTherapy Science Key News & Latest Developments
Table 98. Peptech Company Summary
Table 99. Peptech Synthetic Peptide Vaccine Product Offerings
Table 100. Peptech Synthetic Peptide Vaccine Sales (K Dose), Revenue (US$, Mn) and Average Price (US$/Dose) (2018-2023)
Table 101. Peptech Key News & Latest Developments
Table 102. Pharmasyntez Company Summary
Table 103. Pharmasyntez Synthetic Peptide Vaccine Product Offerings
Table 104. Pharmasyntez Synthetic Peptide Vaccine Sales (K Dose), Revenue (US$, Mn) and Average Price (US$/Dose) (2018-2023)
Table 105. Pharmasyntez Key News & Latest Developments
Table 106. Sumitomo Dainippon Pharma Company Summary
Table 107. Sumitomo Dainippon Pharma Synthetic Peptide Vaccine Product Offerings
Table 108. Sumitomo Dainippon Pharma Synthetic Peptide Vaccine Sales (K Dose), Revenue (US$, Mn) and Average Price (US$/Dose) (2018-2023)
Table 109. Sumitomo Dainippon Pharma Key News & Latest Developments
Table 110. TapImmune Company Summary
Table 111. TapImmune Synthetic Peptide Vaccine Product Offerings
Table 112. TapImmune Synthetic Peptide Vaccine Sales (K Dose), Revenue (US$, Mn) and Average Price (US$/Dose) (2018-2023)
Table 113. TapImmune Key News & Latest Developments
Table 114. Targovax Company Summary
Table 115. Targovax Synthetic Peptide Vaccine Product Offerings
Table 116. Targovax Synthetic Peptide Vaccine Sales (K Dose), Revenue (US$, Mn) and Average Price (US$/Dose) (2018-2023)
Table 117. Targovax Key News & Latest Developments
Table 118. Synthetic Peptide Vaccine Production Capacity (K Dose) of Key Manufacturers in Global Market, 2021-2023 (K Dose)
Table 119. Global Synthetic Peptide Vaccine Capacity Market Share of Key Manufacturers, 2021-2023
Table 120. Global Synthetic Peptide Vaccine Production by Region, 2018-2023 (K Dose)
Table 121. Global Synthetic Peptide Vaccine Production by Region, 2024-2030 (K Dose)
Table 122. Synthetic Peptide Vaccine Market Opportunities & Trends in Global Market
Table 123. Synthetic Peptide Vaccine Market Drivers in Global Market
Table 124. Synthetic Peptide Vaccine Market Restraints in Global Market
Table 125. Synthetic Peptide Vaccine Raw Materials
Table 126. Synthetic Peptide Vaccine Raw Materials Suppliers in Global Market
Table 127. Typical Synthetic Peptide Vaccine Downstream
Table 128. Synthetic Peptide Vaccine Downstream Clients in Global Market
Table 129. Synthetic Peptide Vaccine Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Synthetic Peptide Vaccine Segment by Type in 2022
Figure 2. Synthetic Peptide Vaccine Segment by Application in 2022
Figure 3. Global Synthetic Peptide Vaccine Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Synthetic Peptide Vaccine Market Size: 2022 VS 2030 (US$, Mn)
Figure 6. Global Synthetic Peptide Vaccine Revenue, 2018-2030 (US$, Mn)
Figure 7. Synthetic Peptide Vaccine Sales in Global Market: 2018-2030 (K Dose)
Figure 8. The Top 3 and 5 Players Market Share by Synthetic Peptide Vaccine Revenue in 2022
Figure 9. By Type - Global Synthetic Peptide Vaccine Revenue, (US$, Mn), 2022 & 2030
Figure 10. By Type - Global Synthetic Peptide Vaccine Revenue Market Share, 2018-2030
Figure 11. By Type - Global Synthetic Peptide Vaccine Sales Market Share, 2018-2030
Figure 12. By Type - Global Synthetic Peptide Vaccine Price (US$/Dose), 2018-2030
Figure 13. By Application - Global Synthetic Peptide Vaccine Revenue, (US$, Mn), 2022 & 2030
Figure 14. By Application - Global Synthetic Peptide Vaccine Revenue Market Share, 2018-2030
Figure 15. By Application - Global Synthetic Peptide Vaccine Sales Market Share, 2018-2030
Figure 16. By Application - Global Synthetic Peptide Vaccine Price (US$/Dose), 2018-2030
Figure 17. By Region - Global Synthetic Peptide Vaccine Revenue, (US$, Mn), 2022 & 2030
Figure 18. By Region - Global Synthetic Peptide Vaccine Revenue Market Share, 2018 VS 2022 VS 2030
Figure 19. By Region - Global Synthetic Peptide Vaccine Revenue Market Share, 2018-2030
Figure 20. By Region - Global Synthetic Peptide Vaccine Sales Market Share, 2018-2030
Figure 21. By Country - North America Synthetic Peptide Vaccine Revenue Market Share, 2018-2030
Figure 22. By Country - North America Synthetic Peptide Vaccine Sales Market Share, 2018-2030
Figure 23. US Synthetic Peptide Vaccine Revenue, (US$, Mn), 2018-2030
Figure 24. Canada Synthetic Peptide Vaccine Revenue, (US$, Mn), 2018-2030
Figure 25. Mexico Synthetic Peptide Vaccine Revenue, (US$, Mn), 2018-2030
Figure 26. By Country - Europe Synthetic Peptide Vaccine Revenue Market Share, 2018-2030
Figure 27. By Country - Europe Synthetic Peptide Vaccine Sales Market Share, 2018-2030
Figure 28. Germany Synthetic Peptide Vaccine Revenue, (US$, Mn), 2018-2030
Figure 29. France Synthetic Peptide Vaccine Revenue, (US$, Mn), 2018-2030
Figure 30. U.K. Synthetic Peptide Vaccine Revenue, (US$, Mn), 2018-2030
Figure 31. Italy Synthetic Peptide Vaccine Revenue, (US$, Mn), 2018-2030
Figure 32. Russia Synthetic Peptide Vaccine Revenue, (US$, Mn), 2018-2030
Figure 33. Nordic Countries Synthetic Peptide Vaccine Revenue, (US$, Mn), 2018-2030
Figure 34. Benelux Synthetic Peptide Vaccine Revenue, (US$, Mn), 2018-2030
Figure 35. By Region - Asia Synthetic Peptide Vaccine Revenue Market Share, 2018-2030
Figure 36. By Region - Asia Synthetic Peptide Vaccine Sales Market Share, 2018-2030
Figure 37. China Synthetic Peptide Vaccine Revenue, (US$, Mn), 2018-2030
Figure 38. Japan Synthetic Peptide Vaccine Revenue, (US$, Mn), 2018-2030
Figure 39. South Korea Synthetic Peptide Vaccine Revenue, (US$, Mn), 2018-2030
Figure 40. Southeast Asia Synthetic Peptide Vaccine Revenue, (US$, Mn), 2018-2030
Figure 41. India Synthetic Peptide Vaccine Revenue, (US$, Mn), 2018-2030
Figure 42. By Country - South America Synthetic Peptide Vaccine Revenue Market Share, 2018-2030
Figure 43. By Country - South America Synthetic Peptide Vaccine Sales Market Share, 2018-2030
Figure 44. Brazil Synthetic Peptide Vaccine Revenue, (US$, Mn), 2018-2030
Figure 45. Argentina Synthetic Peptide Vaccine Revenue, (US$, Mn), 2018-2030
Figure 46. By Country - Middle East & Africa Synthetic Peptide Vaccine Revenue Market Share, 2018-2030
Figure 47. By Country - Middle East & Africa Synthetic Peptide Vaccine Sales Market Share, 2018-2030
Figure 48. Turkey Synthetic Peptide Vaccine Revenue, (US$, Mn), 2018-2030
Figure 49. Israel Synthetic Peptide Vaccine Revenue, (US$, Mn), 2018-2030
Figure 50. Saudi Arabia Synthetic Peptide Vaccine Revenue, (US$, Mn), 2018-2030
Figure 51. UAE Synthetic Peptide Vaccine Revenue, (US$, Mn), 2018-2030
Figure 52. Global Synthetic Peptide Vaccine Production Capacity (K Dose), 2018-2030
Figure 53. The Percentage of Production Synthetic Peptide Vaccine by Region, 2022 VS 2030
Figure 54. Synthetic Peptide Vaccine Industry Value Chain
Figure 55. Marketing Channels